Sentinel Lymph Node Mapping Most Cost-Effective for Uterine CA
TUESDAY, Aug. 21, 2018 -- Sentinel lymph node mapping has the lowest costs and highest quality-adjusted survival compared to both routine and selective lymphadenectomy for managing low-risk endometrial carcinoma, according to a study published in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 21, 2018 Category: Pharmaceuticals Source Type: news
Most Postmenopausal Bleeding Not Associated With Cancer
TUESDAY, Aug. 14, 2018 -- Most women with postmenopausal bleeding (PMB) will not be diagnosed with endometrial cancer, according to a review published online Aug. 6 in JAMA Internal Medicine.
Megan A. Clarke, Ph.D., from the National Cancer... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 14, 2018 Category: Pharmaceuticals Source Type: news
Postmenopausal Bleeding and Endometrial Cancer
Postmenopausal Bleeding: Reliable Sign of Endometrial Cancer (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - August 9, 2018 Category: General Medicine Source Type: news
Postmenopausal Bleeding: Reliable Sign of Endometrial Cancer Postmenopausal Bleeding: Reliable Sign of Endometrial Cancer
Almost all women with endometrial cancer have postmenopausal bleeding (PMB), although only a small proportion of women with PMB will be diagnosed with endometrial cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 8, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Postmenopausal Bleeding Should Prompt Endometrial Ca Evaluation
(MedPage Today) -- But patient counseling needed, as only 10% of such cases are cancer (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 7, 2018 Category: Hematology Source Type: news
How common is endometrial cancer in women with postmenopausal bleeding?
(JAMA Network) Postmenopausal bleeding is a common symptom among most women with endometrial cancer but most women with postmenopausal bleeding won't be diagnosed with endometrial cancer, findings that raise questions about how to best manage postmenopausal bleeding for the early detection of endometrial cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 6, 2018 Category: Cancer & Oncology Source Type: news
Women's Wellness: Endometrial cancer -- risk factors, screening, treatment
DEAR MAYO CLINIC:?My sister, who is 56, recently was diagnosed with early-stage endometrial cancer. I?m wondering if this kind of cancer runs in families. Could I be at risk for it, too? Are there other things that can raise a woman?s risk for endometrial cancer? Are there any screening tests available for it? ANSWER:?An increased [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 26, 2018 Category: Databases & Libraries Source Type: news
Extended Tamoxifen May Double Endometrial Cancer Risk
(MedPage Today) -- But observed malignancies were detected early and carried low mortality risk (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - July 10, 2018 Category: Hematology Source Type: news
Top oncologist to study effect of diet on cancer drugs
Siddhartha Mukherjee says trial is first in a series on ‘rethinking human diets for cancer’A groundbreaking clinical trial on whether diet could boost the effectiveness of cancer drugs is set to be launched by one of the world ’s leading oncologists.The work, led bySiddhartha Mukherjee atColumbia University Medical Center in New York, will investigate whether a high-fat, low-carbohydrate diet could improve outcomes for patients with lymphoma and endometrial cancer.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - July 6, 2018 Category: Science Authors: Hannah Devlin Science correspondent Tags: Cancer research Medical research Siddhartha Mukherjee Science Diets and dieting Health Source Type: news
Breast-cancer drug taken by thousands of women doubles the risk of womb cancer
Researchers from St Vincent's Hospital Group, Dublin, found that taking tamoxifen for 10 years rather than five raises the risk of endometrial cancer from 1.5 per cent to 3.5 per cent. (Source: the Mail online | Health)
Source: the Mail online | Health - July 5, 2018 Category: Consumer Health News Source Type: news
Extended tamoxifen therapy may increase risk of endometrial cancer
(Wiley) There is clear evidence that extended adjuvant tamoxifen therapy for 10 years reduces local recurrence and improves breast cancer-free survival in women with oestrogen receptor-positive breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 5, 2018 Category: Cancer & Oncology Source Type: news
Olaparib Plus Vistusertib Promising in Early Trial of Endometrial, Other Cancers
Dave LevitanJun 6, 2018The combination of the PARP inhibitor olaparib with the mTORC1/2 inhibitor vistusertib had promising activity across endometrial, ovarian, and triple-negative breast cancers. (Source: CancerNetwork)
Source: CancerNetwork - June 6, 2018 Category: Cancer & Oncology Authors: A Source Type: news
Gene sequencing study finds new cancers linked with Lynch syndrome
CHICAGO (Reuters) - Lynch syndrome, a rare hereditary disease typically associated with an increased risk of colorectal and endometrial cancers, appears to be linked with several additional types of cancer than previously thought, U.S. researchers said on Saturday. (Source: Reuters: Health)
Source: Reuters: Health - June 2, 2018 Category: Consumer Health News Tags: healthNews Source Type: news
CVD Risk Elevated in Endometrial Ca Survivors (CME/CE)
(MedPage Today) -- Call for careful monitoring, risk management for up to 10 years after cancer diagnosis (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - May 13, 2018 Category: Cardiology Source Type: news
